2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$0.65-$0.03 (-3.77%)
Price as of Oct 22, 2026 6:30 PM EDT- $40.4MMarket Cap
- -87.08%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$0.65-$0.03 (-3.77%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.67 | ||
Change | -$0.06 (-8.72%) | ||
Open | $0.74 | ||
High | $0.75 | ||
Low | $0.66 | ||
Previous Close | $0.73 | ||
Volume | 606,565 | ||
30-Day Average Volume | 1,896,847 | ||
1-Week Change | -15.19% | ||
1-Month Change | -50.35% | ||
1-Year Change | -87.08% | ||
3-Year Change | -59.38% | ||
5-Year Change | -91.77% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $47.5M | ||
Market Cap | $40.4M | ||
Enterprise Value | $60.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $37.7M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue